skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,074  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
m1A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma
m1A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma
Material Type:
Article 		Add to My Research

m1A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma

BMC cancer, 2024-04, Vol.24 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12235-4

Full text available

Citations Cited by
2
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
Material Type:
Article 		Add to My Research

A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential

BMC cancer, 2019-06, Vol.19 (1), p.581-581, Article 581 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5768-0 ;PMID: 31200666

Full text available

Citations Cited by
3
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Material Type:
Article 		Add to My Research

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

BMC cancer, 2019-02, Vol.19 (1), p.132-19, Article 132 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5302-4 ;PMID: 30736741

Full text available

Citations Cited by
4
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Material Type:
Article 		Add to My Research

Clinical effects of curcumin in enhancing cancer therapy: A systematic review

BMC cancer, 2020-08, Vol.20 (1), p.791-11, Article 791 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07256-8 ;PMID: 32838749

Full text available

Citations Cited by
5
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Material Type:
Article 		Add to My Research

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

BMC cancer, 2021-11, Vol.21 (1), p.1-1191, Article 1191 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08848-8 ;PMID: 34753434

Full text available

Citations Cited by
6
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Material Type:
Article 		Add to My Research

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3286-5 ;PMID: 28511673

Full text available

Citations Cited by
7
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients
Material Type:
Article 		Add to My Research

Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients

BMC cancer, 2021-05, Vol.21 (1), p.1-645, Article 645 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08341-2 ;PMID: 34059009

Full text available

Citations Cited by
8
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
Material Type:
Article 		Add to My Research

Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019

BMC cancer, 2021-05, Vol.21 (1), p.1-606, Article 606 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08280-y ;PMID: 34034700

Full text available

Citations Cited by
9
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years
Material Type:
Article 		Add to My Research

Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years

BMC cancer, 2022-07, Vol.22 (1), p.1-836, Article 836 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09940-3 ;PMID: 35907848

Full text available

Citations Cited by
10
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Material Type:
Article 		Add to My Research

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

BMC cancer, 2019-02, Vol.19 (1), p.151-151, Article 151 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5354-5 ;PMID: 30764783

Full text available

Citations Cited by
11
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
Material Type:
Article 		Add to My Research

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

BMC cancer, 2021-05, Vol.21 (1), p.1-622, Article 622 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08373-8 ;PMID: 34044810

Full text available

Citations Cited by
12
A convolutional neural network-based system to classify patients using FDG PET/CT examinations
A convolutional neural network-based system to classify patients using FDG PET/CT examinations
Material Type:
Article 		Add to My Research

A convolutional neural network-based system to classify patients using FDG PET/CT examinations

BMC cancer, 2020-03, Vol.20 (1), p.227-227, Article 227 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-6694-x ;PMID: 32183748

Full text available

Citations Cited by
13
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Material Type:
Article 		Add to My Research

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

BMC cancer, 2015-10, Vol.15 (1), p.767-767, Article 767 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Smith et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1632-z ;PMID: 26497495

Full text available

Citations Cited by
14
Radiographic and [alpha]-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
Radiographic and [alpha]-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
Material Type:
Article 		Add to My Research

Radiographic and [alpha]-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

BMC cancer, 2023-05, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10898-z

Full text available

Citations Cited by
15
Upregulation of pERK and c-JUN by [gamma]-tocotrienol and not [alpha]-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells
Upregulation of pERK and c-JUN by [gamma]-tocotrienol and not [alpha]-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells
Material Type:
Article 		Add to My Research

Upregulation of pERK and c-JUN by [gamma]-tocotrienol and not [alpha]-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells

BMC cancer, 2020-05, Vol.20 (1) [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06947-6

Full text available

Citations Cited by
16
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
Material Type:
Article 		Add to My Research

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

BMC cancer, 2015-08, Vol.15 (1), p.602, Article 602 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Owadally et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1598-x ;PMID: 26311526

Full text available

Citations Cited by
17
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
Material Type:
Article 		Add to My Research

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis

BMC cancer, 2020-04, Vol.20 (1), p.328-328, Article 328 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06805-5 ;PMID: 32299384

Full text available

Citations Cited by
18
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study
Material Type:
Article 		Add to My Research

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study

BMC cancer, 2024-04, Vol.24 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12225-6

Full text available

Citations Cited by
19
Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer
Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer
Material Type:
Article 		Add to My Research

Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer

BMC cancer, 2019-11, Vol.19 (1), p.946-946, Article 946 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6218-8 ;PMID: 31690275

Full text available

Citations Cited by
20
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
Material Type:
Article 		Add to My Research

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

BMC cancer, 2019-12, Vol.19 (1), p.1250-1250, Article 1250 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6442-2 ;PMID: 31881853

Full text available

Citations Cited by

Results 1 - 20 of 1,074  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2013  (59)
  2. 2013 To 2016  (191)
  3. 2017 To 2018  (47)
  4. 2019 To 2021  (500)
  5. After 2021  (277)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait